BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $249,000 | -61.9% | 1,706 | -63.7% | 0.00% | -71.4% |
| Q3 2021 | $653,000 | +12.2% | 4,700 | -21.7% | 0.01% | +16.7% |
| Q2 2021 | $582,000 | -33.8% | 6,000 | -55.6% | 0.01% | -64.7% |
| Q3 2020 | $879,000 | +42.0% | 13,525 | +19.0% | 0.02% | +13.3% |
| Q4 2019 | $619,000 | -84.6% | 11,361 | -88.2% | 0.02% | -87.3% |
| Q3 2019 | $4,026,000 | +1543.3% | 96,500 | +1623.2% | 0.12% | +1211.1% |
| Q2 2019 | $245,000 | -55.1% | 5,600 | -47.2% | 0.01% | -52.6% |
| Q1 2019 | $546,000 | -92.3% | 10,600 | -94.5% | 0.02% | -93.1% |
| Q4 2018 | $7,123,000 | +97.0% | 192,600 | +100.0% | 0.27% | +70.2% |
| Q3 2018 | $3,616,000 | +19.0% | 96,300 | -18.3% | 0.16% | -29.4% |
| Q1 2018 | $3,038,000 | +426.5% | 117,919 | +451.2% | 0.23% | +385.1% |
| Q4 2017 | $577,000 | – | 21,394 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |